BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 2838571)

  • 1. Characterization of a human cytomegalovirus glycoprotein complex (gcI).
    Gretch DR; Gehrz RC; Stinski MF
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1205-15. PubMed ID: 2838571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.
    Britt WJ; Vugler LG
    J Virol; 1989 Jan; 63(1):403-10. PubMed ID: 2535741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140).
    Montalvo EA; Grose C
    J Virol; 1987 Sep; 61(9):2877-84. PubMed ID: 3039175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties.
    Montalvo EA; Parmley RT; Grose C
    J Virol; 1985 Mar; 53(3):761-70. PubMed ID: 2983087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-I (gB).
    Kari B; Liu YN; Goertz R; Lussenhop N; Stinski MF; Gehrz R
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2673-80. PubMed ID: 1701480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glycosylation inhibitors on the structure and function of the murine transferrin receptor.
    Ralton JE; Jackson HJ; Zanoni M; Gleeson PA
    Eur J Biochem; 1989 Dec; 186(3):637-47. PubMed ID: 2514095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of human cytomegalovirus glycoprotein B in recombinant adenovirus-infected cells.
    Marshall GS; Fenger DP; Stout GG; Knights ME; Hunt LA
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1549-57. PubMed ID: 8757998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of the insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptor in rat C6 glial cells: the role of N-linked glycosylation in binding of IGF-II to the receptor.
    Kiess W; Greenstein LA; Lee L; Thomas C; Nissley SP
    Mol Endocrinol; 1991 Feb; 5(2):281-91. PubMed ID: 1645456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of cytomegalovirus infectivity after treatment with castanospermine or related plant alkaloids correlates with aberrant glycoprotein synthesis.
    Taylor DL; Fellows LE; Farrar GH; Nash RJ; Taylor-Robinson D; Mobberley MA; Ryder TA; Jeffries DJ; Tyms AS
    Antiviral Res; 1988 Nov; 10(1-3):11-26. PubMed ID: 2852915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of inhibitors of glycoprotein synthesis and processing on the phagocytosis of rod outer segments by cultured retinal pigment epithelial cells.
    Hall MO; Burgess BL; Arakawa H; Fliesler SJ
    Glycobiology; 1990 Sep; 1(1):51-61. PubMed ID: 2136381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-translational processing and activation of insulin and EGF proreceptors.
    Lane MD; Ronnett G; Slieker LJ; Kohanski RA; Olson TL
    Biochimie; 1985; 67(10-11):1069-80. PubMed ID: 3000457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and processing of the major envelope glycoprotein of murine cytomegalovirus.
    Loh LC
    Virology; 1991 Jan; 180(1):239-50. PubMed ID: 1845824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of swainsonine and castanospermine on the sulfation of the oligosaccharide chains of N-linked glycoproteins.
    Merkle RK; Elbein AD; Heifetz A
    J Biol Chem; 1985 Jan; 260(2):1083-9. PubMed ID: 3918027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes.
    Duperray A; Berthier R; Chagnon E; Ryckewaert JJ; Ginsberg M; Plow E; Marguerie G
    J Cell Biol; 1987 Jun; 104(6):1665-73. PubMed ID: 3108266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor.
    Lublin DM; Krsek-Staples J; Pangburn MK; Atkinson JP
    J Immunol; 1986 Sep; 137(5):1629-35. PubMed ID: 2427577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inhibiting N-glycosylation or oligosaccharide processing on vasoactive intestinal peptide receptor binding activity and structure.
    el Battari A; Forget P; Fouchier F; Pic P
    Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):527-33. PubMed ID: 1654885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and processing of the Marek's disease herpesvirus B antigen glycoprotein complex.
    Sithole I; Lee LF; Velicer LF
    J Virol; 1988 Nov; 62(11):4270-9. PubMed ID: 2845139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein.
    Poss ML; Quackenbush SL; Mullins JI; Hoover EA
    J Virol; 1990 Sep; 64(9):4338-45. PubMed ID: 2166820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inhibitors of oligosaccharide processing on P0 protein synthesis and incorporation into PNS myelin.
    Smith ME
    J Neurochem; 1991 Aug; 57(2):655-64. PubMed ID: 1712832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation and secretion of surfactant-associated glycoprotein A.
    Whitsett JA; Ross G; Weaver T; Rice W; Dion C; Hull W
    J Biol Chem; 1985 Dec; 260(28):15273-9. PubMed ID: 2866181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.